Intuitive Surgical, Inc. $ISRG Holdings Decreased by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,783,243 shares of the medical equipment provider’s stock after selling 686,369 shares during the period. Intuitive Surgical accounts for 0.8% of Price T Rowe Associates Inc. MD’s portfolio, making the stock its 16th biggest holding. Price T Rowe Associates Inc. MD owned about 3.85% of Intuitive Surgical worth $6,826,428,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. Chilton Capital Management LLC lifted its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the period. Global Financial Private Client LLC boosted its stake in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 38 shares in the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter worth about $26,000. Finally, LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Piper Sandler reaffirmed an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Citigroup reiterated a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. UBS Group upped their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Stock Up 0.3%

Intuitive Surgical stock opened at $480.45 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a market cap of $172.23 billion, a P/E ratio of 67.01, a P/E/G ratio of 5.02 and a beta of 1.59. The company’s fifty day simple moving average is $506.00 and its 200-day simple moving average is $523.53.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the business earned $1.78 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 7,893 shares of the firm’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the transaction, the insider directly owned 13,187 shares in the company, valued at $6,575,565.68. This trade represents a 37.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company’s stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,839 shares of company stock worth $7,896,972 in the last 90 days. 0.70% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.